ArticleThe Journal of rheumatology2011
Patient-reported outcomes in chronic gout: a report from OMERACT 10.
Article in The Journal of rheumatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 9 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 9 syntheses or guidelines pooled it, 104 citations in OpenAlex.
- Colchicine for acute gout.The Cochrane database of systematic reviews · 2021Pooled it
- A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties.Health and quality of life outcomes · 2019Pooled it
- Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies.Annals of the rheumatic diseases · 2017Pooled it
- Uricosuric medications for chronic gout.The Cochrane database of systematic reviews · 2014Pooled it
- Allopurinol for chronic gout.The Cochrane database of systematic reviews · 2014Pooled it
- Outcome measures in acute gout: a systematic literature review.The Journal of rheumatology · 2014Pooled it
- Lifestyle interventions for acute gout.The Cochrane database of systematic reviews · 2013Pooled it
- Health-related quality of life in gout: a systematic review.Rheumatology (Oxford, England) · 2013Pooled it
- Lifestyle interventions for chronic gout.The Cochrane database of systematic reviews · 2013Pooled it
- Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH).Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2020Trial
- A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2020Trial
- Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial.Arthritis research & therapy · 2019Trial
- Evaluation of measurement properties of the Health Assessment Questionnaire-Disability Index (HAQ-DI) among gout patients in China.Health and quality of life outcomes · 2025Article
- Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.Drugs & aging · 2025Article
- Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study.Rheumatology (Oxford, England) · 2025Observational
- Risk factors for loss to follow-up in patients with gout: A Korean prospective cohort study.PloS one · 2025Article
- Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis.Rheumatology and therapy · 2024Article
- High vegetable consumption and regular exercise are associated with better quality of life in patients with gout.The Korean journal of internal medicine · 2024Article
- Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study.Rheumatology (Oxford, England) · 2023Article
- Reliability and Validity of the Korean Version of the Gout Impact Scale.Journal of Korean medical science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 11 institutions in 5 countries.
Funding
Abstract
objectiveTo summarize the endorsement of measures of patient-reported outcome (PRO) domains in chronic gout at the 2010 Outcome Measures in Rheumatology Meeting (OMERACT 10).
methodsDuring the OMERACT 10 gout workshop, validation data were presented for key PRO domains including pain [pain by visual analog scale (VAS)], patient global (patient global VAS), activity limitation [Health Assessment Questionnaire-Disability Index (HAQ-DI)], and a disease-specific measure, the Gout Assessment Questionnaire version 2.0 (GAQ v2.0). Data were presented on all 3 aspects of the OMERACT filters of truth, discrimination, and feasibility. One PRO, health-related quality of life measurement with the Medical Outcomes Study Short-form 36 (SF-36), was previously endorsed at OMERACT 9.
resultsOne measure for each of the 3 PRO of pain, patient global, and activity limitation was endorsed by > 70% of the OMERACT delegates to have appropriate validation data. Specifically, pain measurement by VAS was endorsed by 85%, patient global assessment by VAS by 73%, and activity limitation by HAQ-DI by 71%. GAQ v2.0 received 30% vote and was not endorsed due to several concerns including low internal consistency and lack of familiarity with the measure. More validation studies are needed for this measure.
conclusionWith the endorsement of one measure each for pain, patient global, SF-36, and activity limitation, all 4 PRO for chronic gout have been endorsed. Future validation studies are needed for the disease-specific measure, GAQ v2.0. Validation for PRO for acute gout will be the focus of the next validation exercise for the OMERACT gout group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.